Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study

被引：0
作者：
Dhayana Dallmeier
Martin G Larson
Ramachandran S Vasan
John F Keaney
Joao D Fontes
James B Meigs
Caroline S Fox
Emelia J Benjamin
机构：
[1] Boston University School of Medicine,General Internal Medicine Division
[2] National Heart,Cardiology, Whitaker Cardiovascular Institute
[3] Lung,Preventive Medicine Divisions, Whitaker Cardiovascular Institute
[4] and Blood Institute’s and Boston University’s Framingham Heart Study,Biostatistics Department
[5] Boston University School of Medicine,Epidemiology Department
[6] Boston University School of Medicine,Department of Medicine
[7] Boston University School of Public Health,Department of Mathematics and Statistics
[8] Boston University School of Public Health,Cardiovascular Medicine
[9] Harvard Medical School,Department of Endocrinology, Diabetes, and Metabolism
[10] Boston University,undefined
[11] University of Massachusetts Medical School,undefined
[12] Brigham and Women’s Hospital and Harvard Medical School,undefined
来源：
Diabetology & Metabolic Syndrome | / 4卷
关键词：
Metabolic syndrome; Inflammatory biomarkers; Body mass index; Insulin resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 213 条
[1]  
Hotamisligil GS(2006)Inflammation and metabolic disorders Nature 444 860-867
[2]  
Pischon T(2008)Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men Atherosclerosis 197 392-399
[3]  
Hu FB(2006)The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease Am J Cardiol 97 11-13
[4]  
Rexrode KM(2006)Cardiovascular death and the metabolic syndrome: role of adiposity-signaling hormones and inflammatory markers Diabetes Care 29 1363-1369
[5]  
Girman CJ(2004)Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 433-438
[6]  
Manson JE(2001)Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 683-689
[7]  
Rimm EB(2003)NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older Diabetes 52 1210-1214
[8]  
Haffner SM(2002)The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 2709-2716
[9]  
Langenberg C(2007)Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome Diabetes Res Clin Pract 75 235-240
[10]  
Bergstrom J(2009)Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study Eur J Clin Invest 39 437-444
12345678910